June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Multiple glycinergic subunits mediate inhibitory inputs to mouse ON-OFF Direction Selective Ganglion Cells
Author Affiliations & Notes
  • Chase B Hellmer
    Ophthalmology and Visual Sciences, University of Louisville School of Medicine, Louisville, Kentucky, United States
  • Ian Pyle
    Ophthalmology and Visual Sciences, University of Louisville School of Medicine, Louisville, Kentucky, United States
  • Caitlin White
    Ophthalmology and Visual Sciences, University of Louisville School of Medicine, Louisville, Kentucky, United States
  • Chi Zhang
    University of Washington Department of Biological Structure, Seattle, Washington, United States
  • Maureen A McCall
    Ophthalmology and Visual Sciences, University of Louisville School of Medicine, Louisville, Kentucky, United States
  • Footnotes
    Commercial Relationships   Chase Hellmer None; Ian Pyle None; Caitlin White None; Chi Zhang None; Maureen McCall None
  • Footnotes
    Support  NIH Grant EY029719
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 4571 – F0433. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Chase B Hellmer, Ian Pyle, Caitlin White, Chi Zhang, Maureen A McCall; Multiple glycinergic subunits mediate inhibitory inputs to mouse ON-OFF Direction Selective Ganglion Cells. Invest. Ophthalmol. Vis. Sci. 2022;63(7):4571 – F0433.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Retinal amacrine cells provide one of two sources of inhibition (GABA or glycine) to ganglion cells (GCs). Various roles for GABAergic inhibition have been discovered. For example, in ON-OFF Direction Selective GCs (ON-OFF-DSGCs), asymmetric GABAergic input restricts sensitivity to objects moving in only one direction. While ON-OFF DSGCs also receive glycinergic input, its function has not been examined. Here we examined GlyRα mediated synaptic inputs and their light evoked currents in WT and GlyRα knockout ON-OFF-DSGCs.

Methods : We pharmacologically isolated glycinergic inputs by eliminating GABAA/GABAC inputs (PTX and TPMPA) and verified the remaining currents were glycinergic using strychnine. Whole-cell patch clamp recording assessed spontaneous glycinergic currents (sIPSCs) from GFP labeled ON-OFF DSGCs in TRHR mice. GlyRα subunit composition was predicted from known sIPSC decay τ's and tested in mice lacking specific GlyRα subunits (KO mice). Glycinergic light-evoked inhibitory postsynaptic currents (L-IPSCs) were compared between WT and GlyRα KO TRHR cells to evaluate the contribution of GlyRα 2, 3 or 4 inputs at light onset and offset.

Results : Isolating glycinergic inputs reduced the L-IPSC amplitude by ~45% in TRHR ON-OFF DSGCs, indicating that glycine mediates a significant inhibitory input. In WT TRHR GCs, the median sIPSC decay τ was 11.3 ms and this shifted to a slower decay τ of 13.9ms in TRHR/GlyRα3-KO mice. This indicates that the remaining currents should be mediated by GlyRα2 or GlyRα4. The median decay τ was similar in TRHR/GlyRα2-KO and TRHR/GlyRα4-KO GCs, which is inconsistent with their predicted decay τ's (~20 vs 40 msec, respectively). Ongoing studies of glycinergic sIPSCs and L-IPSCs in TRHR double KOs: GlyRα2/GlyRα3 and GlyRα3/GlyRα4 will determine if one or both provide synaptic input.

Conclusions : Our results clearly show that glycinergic currents represent a significant source of inhibition to TRHR ON-OFF-DSGCs. These GCs receive predominant synaptic input via GlyRα3 and an additional input from GlyRα's with slower decay τ's. The different decay kinetics between GlyRα3 (fast τ decays) and GlyRα2 and GlyRα4 (slow τ decays) could lead to subunit specific inhibition in ON-OFF DSGCs on different time scales. Ongoing analyses of light evoked responses will evaluate the functional contributions GlyRα mediated input in ON-OFF DSGCs.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×